Kinesio-Taping and Chest Physiotherapy Program After Mastectomy
Efficacy of Combined Kinesio-Taping With Chest Physiotherapy Program on Pain, Pulmonary Function, Respiratory Muscle Strength and Quality of Life After Mastectomy: A Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
The modified radical mastectomy (MRM) is a major surgical approach that necessitates the dissection of axillary lymph nodes. As a result, there is more bleeding and the treatment takes longer time. This treatment is used to treat locally advanced breast cancer. Numerous factors, including pain and respiratory depression from general anaesthesia, can impair respiratory function during the post-operative period. Pain causes the thoracic cage's post-operative movement to be restricted and the breathing muscles to become inhibited.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2024
CompletedFirst Posted
Study publicly available on registry
November 22, 2024
CompletedStudy Start
First participant enrolled
December 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2025
CompletedAugust 8, 2025
December 1, 2024
6 months
November 20, 2024
August 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
visual analogue scale
The visual representation of the pain range that a patient thinks they might experience is called a linear scale. The score is ranged from 0 to 10. The least the score, the better results. While, the higher the score, the worst the results.
4 weeks
Secondary Outcomes (5)
Forced vital capacity (FVC)
4 weeks
forced expiratory volume at first second (FEV1)
4 weeks
Forced expiratory volume at first second /Forced vital capacity ratio.
4 weeks
Respiratory muscle strength
4 weeks
Quality of life
4 weeks
Study Arms (2)
Group A (Kinesiotaping group)
EXPERIMENTALParticipants will be seated on a chair, KT will be applied bilaterally at the end of the expiration on the fifth to sixth and ninth to tenth intercostal muscles transversally and on the anterior and posterior axillary line longitudinally with 50% tension. In order to stimulate the muscle and support the function, the stimulation technique is usually applied from the origin to the insertion of the muscle with the recommended stretching of 25 to 50%. Additionally, traditional physical therapy program will be conducted to participants in the study group.
Group B (control group)
ACTIVE COMPARATORThey will receive the chest physical therapy program which is consisted of deep breathing exercises, postural drainage, cough, 3 times /week for 4 weeks.
Interventions
Participants will be seated on a chair, KT will be applied bilaterally at the end of the expiration on the fifth to sixth and ninth to tenth intercostal muscles transversally and on the anterior and posterior axillary line longitudinally with 50% tension. In order to stimulate the muscle and support the function, the stimulation technique is usually applied from the origin to the insertion of the muscle with the recommended stretching of 25 to 50%.
The chest physical therapy program is consisted of deep breathing exercises, postural drainage, and cough.
Eligibility Criteria
You may qualify if:
- Females aged between 30 and 50 years
- Participants after modified radical mastectomy
- Participants able to comprehend instructions.
- Cooperative participants, and willing to participate in the study.
You may not qualify if:
- Participants having sensitive skin, scars, or lesions.
- Participants with unhealed incisions at the site of application.
- Participants with uncontrolled diabetes.
- Participants with deep vein thrombosis.
- Participants with previous chest diseases.
- Pregnancy.
- Participants with altered sensations.
- Participants with allodynia.
- Participants with active infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of physical therapy
Giza, Giza Governorate, 1124, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Hadaya M Eladl, PhD
Assisstant professor of physical therapy for surgery, Faculty of physical therapy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of physical therapy for surgery, Faculty of physical therapy
Study Record Dates
First Submitted
November 20, 2024
First Posted
November 22, 2024
Study Start
December 20, 2024
Primary Completion
June 30, 2025
Study Completion
July 30, 2025
Last Updated
August 8, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 6 months after publication